beta-Sitosterol

Star2

DB14038InvestigationalSmall molecule

Active fraction of Solanum trilobatum; reduces side-effects of radiation-induced toxicity.

Formula / weight: C₂₉H₅₀O · 414.718 g/mol (avg)
Also known as: 22,23-Dihydrostigmasterol · Azuprostat · Cupreol · Nimbosterol · Sitosterol
Code names: SKF 14463

Resolves to

Compound

UNIIS347WMO6M4CAS83-46-5ChEMBLCHEMBL221542ChEBI27693KEGGD08518

Clinical / RWD

RxNorm47070

Structure

InChIKeyKZJWDPNRJALLNS-VJSFXXLFSA-NSMILES[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CC[C@@H](CC)C(C)C

Targets

P22680CYP7A1

What you can answer from here — as of July 11, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

3Structured indicationsCondition, population, route and combination as fields, not prose

8Marketed productsAcross 2 countries and 7 labellers

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with beta-Sitosterol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account